ACRIVON THERAPEUTICS INC (ACRV) Stock Cash Flow
USA - NASDAQ:ACRV - US0048901096 - Common Stock
1.605 USD
+0.02 (+1.58%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -85.96M | -80.56M | -60.39M | -31.17M | -16.24M | |||
| Depreciation Amortization | 1.20M | 1.01M | 536.00K | 360.00K | 40.00K | |||
| Change In Working Capital | 486.00K | 2.44M | 8.14M | -1.53M | 330.00K | |||
| Other non cash items | 13.44M | 11.44M | 9.07M | 2.22M | 1.90M | |||
| OPERATING CASH FLOW | -70.83M | -65.67M | -42.64M | -30.12M | -13.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.37M | -2.77M | -1.29M | -2.17M | -240.00K | |||
| Other Investing Activity | 71.45M | -49.00M | 52.01M | -139.51M | N/A | |||
| INVESTING CASH FLOW | 69.09M | -51.77M | 50.72M | -141.68M | -240.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | -306.00K | 123.55M | -257.00K | 1.90M | 112.22M | |||
| Other Financing Activity | -2.29M | -2.52M | -1.30M | 99.81M | N/A | |||
| FINANCING CASH FLOW | -2.59M | 121.03M | -1.55M | 101.71M | 112.22M | |||
| CHANGE IN CASH | -4.33M | 3.59M | 6.52M | -70.09M | 98.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -70.83M | -65.67M | -42.64M | -30.12M | -13.98M | |||
| Capital Expenditure | -2.37M | -2.77M | -1.29M | -2.17M | -240.00K | |||
| FREE CASH FLOW | -73.19M | -68.44M | -43.93M | -32.29M | -14.22M | |||
All data in USD